CTMX
CytomX TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CTMX vs peer average
46/100
CTMX vs. peer average (C vs. C)
Grade spread
A 2 · B 2 · C 2 · D 2 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
LXEO is the first available peer comparator.
Clinical-stage small-cap biotech with similar financing and milestone sensitivity; useful as a runway/readout comparator, though not a direct mechanistic peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CTMX
CytomX Therapeutics
LXEO
Lexeo Therapeutics
Grade
C
F
Momentum
8
8
Value
53
41
Sentiment
100
0
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs LXEO
CTMX / LXEO
Grade Position
In line
CTMX vs. peer average (C vs. C)
46/100
Momentum
8
CTMXValue
53
CTMXSentiment
100
CTMXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CTMX
LXEO is the first peer returned for this comparison set.